8 recruiting, 5 not yet recruiting, 3 unknown, 2 withdrawn. 6 Phase 2, 4 Phase 1, 3 Not applicable, 2 Phase 3, 2 Phase 4.
Follow ITP - Immune Thrombocytopenia: new trials by email Literature Review of ITP - Immune Thrombocytopenia trials Research Report on ITP - Immune Thrombocytopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease CTX112 - Warm Autoimmune Hemolytic Anemia (WAIHA), ITP - Immune Thrombocytopenia | Phase 1 / Phase 2 | Recruiting | CRISPR Therapeutics AG | 60 | 2026-07-17 | 2026-10-20 |
| TPO-RA Plus Baricitinib vs. TPO-RA for ITP Baricitinib, TPO-RA - ITP - Immune Thrombocytopenia | Phase 2 | Not yet recruiting | Peking University People's Hospital | 100 | 2026-07-01 | 2026-06-25 |
| Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia standard-dose methylprednisolone/prednisone., thrombopoietin receptor agonist(TPO-RA), including but not limited to hetrombopag or eltrombopag., rituximab. - ITP - Immune Thrombocytopenia | Phase 4 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 38 | 2026-06-22 | 2026-08-26 |
| Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia Avatrombopag+All trans retinoic acid, Avatrombopag - ITP - Immune Thrombocytopenia | Phase 2 / Phase 3 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 248 | 2025-12-01 | 2025-12-12 |
| A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP) Efgartigimod IV, Placebo IV - Immune Thrombocytopenia (ITP), ITP - Immune Thrombocytopenia | Phase 2 / Phase 3 | Recruiting | argenx | 24 | 2025-10-20 | 2026-11-16 |
| "Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children" ITP - Immune Thrombocytopenia | Not yet recruiting | Sohag University | 80 | 2025-08-20 | 2025-06-17 | |
| OM336 in Autoimmune Cytopenias OM336 - AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia | Phase 1 | Recruiting | Lakefront Biotherapeutics West LLC | 32 | 2025-08-01 | 2026-09-03 |
| Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura Eltrombopag - ITP - Immune Thrombocytopenia | Not applicable | Recruiting | Sohag University | 100 | 2025-07-14 | 2025-07-30 |
| Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study Avatrombopag 20 mg Oral Tablet - ITP - Immune Thrombocytopenia | Phase 4 | Recruiting | Al-Mustansiriyah University | 25 | 2025-06-08 | 2025-08-21 |
| Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure Ripertamab/Eltrombopag, Eltrombopag - ITP - Immune Thrombocytopenia | Not applicable | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 78 | 2025-02-01 | 2025-01-24 |
| Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia MSC - ITP - Immune Thrombocytopenia | Not applicable | Withdrawn | Guangzhou Bio-gene Technology Co., Ltd | 2024-11-11 | 2026-05-28 | |
| RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia ITP - Immune Thrombocytopenia, Primary Immune Thrombocytopenia (ITP) | Recruiting | Fundación Española de Hematología y Hemoterapía | 1000 | 2024-09-27 | 2025-04-09 | |
| The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) HMPL-523 - Immune Thrombocytopenia, Blood Platelet Disorder | Phase 1 | Withdrawn | Hutchmed | 2024-04-02 | 2025-09-16 | |
| Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP) CAR-T cells - ITP - Immune Thrombocytopenia | Phase 1 / Phase 2 | Recruiting | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 10 | 2024-02-01 | 2024-07-22 |
| Immune Markers in Pediatric ITP on Second Line Therapy complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ. - ITP - Immune Thrombocytopenia | Unknown | Assiut University | 42 | 2024-01-01 | 2023-11-14 | |
| Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura eltrombopag and romiplastim - ITP - Immune Thrombocytopenia | Not yet recruiting | Assiut University | 100 | 2023-12-01 | 2023-11-18 | |
| High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial hetrombopag 5mg po qd, High-dose Dexamethasone - ITP - Immune Thrombocytopenia | Phase 2 | Unknown | Shandong University | 100 | 2023-09-15 | 2023-09-26 |
| Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP Fostamatinib - ITP - Immune Thrombocytopenia, Chronic ITP | Completed | Gruppo Italiano Malattie EMatologiche dell'Adulto | 95 | 2023-05-05 | 2025-04-30 | |
| Explore the Relationship Between Platelet Count and Bleeding Score in ITP ITP - Immune Thrombocytopenia | Unknown | Assiut University | 100 | 2022-04-10 | 2024-02-23 |
Purpura, Thrombocytopenic, Idiopathic (19) · Thrombocytopenia (2) · Anemia, Hemolytic, Autoimmune (1) · Autoimmune Diseases (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Hematologic Diseases (1) · Hemorrhage (1) · Hemorrhagic Disorders (1) · Immune System Diseases (1) · Pathologic Processes (1) · Purpura (1) · Purpura, Thrombocytopenic (1) · Skin Manifestations (1) · Thrombotic Microangiopathies (1)
Cytopenia (19) · Hemic and Lymphatic Diseases (19) · Pathological Conditions, Signs and Symptoms (19) · Signs and Symptoms (19) · Autoimmune Diseases (18) · Blood Coagulation Disorders (18) · Blood Platelet Disorders (18) · Hematologic Diseases (18) · Hemorrhage (18) · Hemorrhagic Disorders (18) · Immune System Diseases (18) · Pathologic Processes (18) · Purpura (18) · Purpura, Thrombocytopenic (18) · Skin Manifestations (18)
eltrombopag (5) · avatrombopag (2) · hetrombopag (2) · Adrenal Cortex Hormones (1) · Blood Cell Count (1) · CD4 Lymphocyte Count (1) · Dexamethasone (1) · Immunotherapy, Adoptive (1) · Methylprednisolone (1) · Prednisone (1) · Rituximab (1) · Tablets (1) · baricitinib (1) · daratumumab (1) · fostamatinib (1)
Assiut University (3) · Institute of Hematology & Blood Diseases Hospital, China (2) · Sohag University (2) · 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China (1) · Al-Mustansiriyah University (1) · CRISPR Therapeutics AG (1) · Fundación Española de Hematología y Hemoterapía (1) · Gruppo Italiano Malattie EMatologiche dell'Adulto (1) · Guangzhou Bio-gene Technology Co., Ltd (1) · Hutchmed (1) · Lakefront Biotherapeutics West LLC (1) · Peking University People's Hospital (1) · Shandong University (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · argenx (1)
China (4) · Spain (4) · Germany (3) · United States (3) · Australia (2) · Egypt (2) · Italy (2) · France (1) · Iraq (1) · Japan (1) · Lithuania (1) · Norway (1) · Poland (1) · Romania (1) · Serbia (1)
Azhar A Mohammed, M.D. (1) · Francesco Zaja (1) · Khaled I El-sayeh, M.D. (1) · Lei Zhang (1) · Mostafa M Embaby, M.D. (1) · Rania Mohammed Mahmoud Hafez, professor (1) · Sanbin Wang, Doctor (1) · William Schelman, MD, PhD (1) · Yousreyia Abdel Rahman Ahmed, professor (1)
2025 (1)